Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii

被引：0
作者：
M. H. Rigatto
V. B. Ribeiro
D. Konzen
A. P. Zavascki
机构：
[1] Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul,Infectious Diseases Service
[2] Hospital de Clínicas de Porto Alegre,Laboratory of Microbiology
[3] Pontifícia Universidade Católica do Rio Grande do Sul,School of Medicine
[4] Hospital de Clínicas de Porto Alegre,Infectious Diseases Service
来源：
Infection | 2013年 / 41卷
关键词：
Polymyxin B; Colistin; Ventilator-associated pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 328
页数：7
相关论文
共 50 条
  • [31] Stable Polymyxin B Susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite Persistent Recovery of These Organisms from Respiratory Secretions of Patients with Ventilator-Associated Pneumonia Treated with This Drug
    Zavascki, Alexandre P.
    Li, Jian
    Nation, Roger L.
    Superti, Silvana V.
    Barth, Afonso L.
    Lutz, Larissa
    Ramos, Fabiano
    Boniatti, Marcio M.
    Goldani, Luciano Z.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (09) : 3064 - 3065
  • [32] Management of Ventilator-Associated Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center: A Randomized Controlled Study
    Abdelhalim, Mona Moheyeldin
    El Sherbini, Seham Awad
    Ahmed, El Shimaa Salah
    Gharib, Heba Abdullah Abdalbaset
    Elgendy, Marwa O.
    Ibrahim, Ahmed R. N.
    Aziz, Heba Sherif Abdel
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [33] Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review
    Celik, Istemi Han
    Oguz, Serife Suna
    Demirel, Gamze
    Erdeve, Omer
    Dilmen, Ugur
    EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (02) : 311 - 316
  • [34] Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review
    İstemi Han Celik
    Serife Suna Oguz
    Gamze Demirel
    Omer Erdeve
    Ugur Dilmen
    European Journal of Pediatrics, 2012, 171 : 311 - 316
  • [35] Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
    Inchai J.
    Pothirat C.
    Bumroongkit C.
    Limsukon A.
    Khositsakulchai W.
    Liwsrisakun C.
    Journal of Intensive Care, 3 (1)
  • [36] Polymyxin B Peptide Hydrogel Coating: A Novel Approach to Prevent Ventilator-Associated Pneumonia
    Wouters, Milan
    Van Moll, Laurence
    De Vooght, Linda
    Choinska, Emilia
    Idaszek, Joanna
    Szlazak, Karol
    Heljak, Marcin K.
    Swieszkowski, Wojciech
    Cos, Paul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [37] In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
    Zhang, Hui
    Zhu, Yunzhu
    Yang, Ning
    Kong, Qinxiang
    Zheng, Yahong
    Lv, Na
    Chen, Haoran
    Yue, Chengcheng
    Liu, Yanyan
    Li, Jiabin
    Ye, Ying
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 4657 - 4666
  • [38] Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species
    Medina, Julio
    Formento, Carlos
    Pontet, Julio
    Curbelo, Andrea
    Bazet, Cristina
    Gerez, Jorge
    Larranaga, Eduardo
    JOURNAL OF CRITICAL CARE, 2007, 22 (01) : 18 - 26
  • [39] Impact of colistin-initiation delay on mortality of ventilator-associated pneumonia caused by A-baumannii
    Samrah, Shaher
    Bashtawi, Yazan
    Hayajneh, Wail
    Almomani, Basima
    Momany, Suleiman
    Khader, Yousef
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (10): : 1129 - 1134
  • [40] Nebulized Antibiotics for Multidrug-Resistant Ventilator-Associated Pseudomonas aeruginosa Pneumonia
    Gilbert, David N.
    CRITICAL CARE MEDICINE, 2019, 47 (06) : 880 - 881
12345